+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Coronary Embolic Protection Device Market | US | Units Sold, Average Selling Prices, Product Pipeline, Forecasts | 2018-2024| MedCore - Product Thumbnail Image

Coronary Embolic Protection Device Market | US | Units Sold, Average Selling Prices, Product Pipeline, Forecasts | 2018-2024| MedCore

  • Report
  • March 2018
  • United States
From
Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • October 2023
  • 259 Pages
  • Global
From
Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • September 2023
  • 50 Pages
  • Global
From
Heart Failure Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Heart Failure Epidemiology Analysis and Forecast to 2032

  • Report
  • September 2023
  • 75 Pages
  • Global
From
Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032

  • Report
  • June 2023
  • 57 Pages
  • Global
From
Atrial Fibrillation Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Atrial Fibrillation Epidemiology Analysis and Forecast to 2032

  • Report
  • June 2023
  • 65 Pages
  • Global
From
Venous Thromboembolism Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032 - Product Thumbnail Image

Venous Thromboembolism Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032

  • Drug Pipelines
  • June 2023
  • 122 Pages
  • Global
From
Dyslipidemia Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Dyslipidemia Epidemiology Analysis and Forecast to 2032

  • Report
  • May 2023
  • 57 Pages
  • Global
From
Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • April 2023
  • 78 Pages
  • Global
From
Aneurysm Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Aneurysm Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 187 Pages
  • Global
From
Heart Failure (HF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Heart Failure (HF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 81 Pages
  • Global
From
Pulmonary Arterial Hypertension Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Pulmonary Arterial Hypertension Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • December 2022
  • 519 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029

  • Drug Pipelines
  • December 2022
  • 107 Pages
  • Global
From
Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • November 2022
  • 94 Pages
  • Global
From
Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 565 Pages
  • Global
From
Pulmonary Embolism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Pulmonary Embolism Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 411 Pages
  • Global
From
Arteriosclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Arteriosclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 864 Pages
  • Global
From
Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2022
  • 68 Pages
  • Global
From
Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • June 2022
  • 101 Pages
  • Global
From
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 208 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more